PTPN9 and gastric cancer: It is demonstrated in gastric cancer cells whereby hsa-miR-181a-5p has been extensively studied and reported as a potential regulator of MEG2, a tumour suppressor gene [31], regulated RASSF6, and in combination predicts poor prognosis in gastric cancer [32].